These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5396486)

  • 21. [Treatment of herpes simplex virus infections].
    Ishak R; Pinheiro Fde P
    Rev Paul Med; 1982; 100(2):25-9. PubMed ID: 6763755
    [No Abstract]   [Full Text] [Related]  

  • 22. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
    Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
    J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
    Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
    J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymine arabinoside (Ara-T) topical and iontophoretic application for herpes simplex virus type 1 and type 2 skin infections in hairless mice.
    Hill JM; Wiggins CA; Kwon BS; Gentry GA; Gangarosa LP
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):17-20. PubMed ID: 6717166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine.
    Shannon WM; Westbrook L; Higuchi WI; Sugibayashi K; Baker DC; Kumar SD; Fox JL; Flynn GL; Ho NF; Vaidyanathan R
    J Pharm Sci; 1985 Nov; 74(11):1157-61. PubMed ID: 4087174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Herpes simplex virus infection in the newborn].
    Shentov B; Tanchev S
    Akush Ginekol (Sofiia); 2005; 44(5):53-7. PubMed ID: 16313056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The N6-(dimethylamino)methylene derivative of 9-beta-D-arabinofuranosyladenine as an antiviral agent.
    Hanessian S
    J Med Chem; 1973 Mar; 16(3):290-2. PubMed ID: 4354694
    [No Abstract]   [Full Text] [Related]  

  • 28. [Interferon therapy for herpes simplex virus infection in a 70 years old patient].
    López García F; Enríquez Ascarza R; Rodríguez Martínez JC; Sirvent Pedreño AE
    An Med Interna; 2002 Nov; 19(11):600-1. PubMed ID: 12522901
    [No Abstract]   [Full Text] [Related]  

  • 29. Betadine for herpes simplex infection.
    Waters LJ; Barton SE; Boag FC
    Int J STD AIDS; 2006 Dec; 17(12):854-5. PubMed ID: 17212866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an aciclovir implant for the effective long-term control of herpes simplex virus type-1 infection in Vero cells and in experimentally infected SKH-1 mice.
    Johnson TP; Frey R; Modugno M; Brennan TP; Margulies BJ
    Int J Antimicrob Agents; 2007 Nov; 30(5):428-35. PubMed ID: 17851051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early foscarnet failure in herpes simplex virus infection in a patient with AIDS.
    Segal BH; Engler HD; Little R; Wilson WH; Freifeld AG; Chanock SJ
    AIDS; 1997 Mar; 11(4):552-3. PubMed ID: 9084815
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiviral drugs for the neonate--the risk-benefit ledger.
    Brunell P
    J Pediatr; 1975 Feb; 86(2):317-8. PubMed ID: 163110
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiviral therapy for neonatal herpes simplex virus: a cost-effectiveness analysis.
    Mennemeyer ST; Cyr LP; Whitley RJ
    Am J Manag Care; 1997 Oct; 3(10):1551-8. PubMed ID: 10178461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
    Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
    Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral activity of a carrageenan from Gigartina skottsbergii against intraperitoneal murine herpes simplex virus infection.
    Pujol CA; Scolaro LA; Ciancia M; Matulewicz MC; Cerezo AS; Damonte EB
    Planta Med; 2006 Feb; 72(2):121-5. PubMed ID: 16491446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of varicella zoster and herpes simplex virus-induced diseases. 2: References for implementing and indications for virustatic therapy].
    Mahler V; Schuler G
    Hautarzt; 2001 Jun; 52(6):554-73. PubMed ID: 11428090
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
    Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
    Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the clinical and experimental chemotherapy of virus infections].
    Rohde B; Hellmig HP
    Z Haut Geschlechtskr; 1967 Mar; 42(6):185-200. PubMed ID: 5582565
    [No Abstract]   [Full Text] [Related]  

  • 39. Medical treatment of herpes.
    Kaufman HE
    Isr J Med Sci; 1972; 8(8):1231-4. PubMed ID: 4630596
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of desoxyribonuclease on herpes simplex virus].
    Kossak NI
    Mikrobiol Zh; 1967; 29(4):312-6. PubMed ID: 4310245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.